Social functioning · adults with antisocial personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with antisocial personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
IRLS all dopamine agonists · patients with restless legs syndrome
1 finding from 1 review
Aggression · adults with antisocial personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reconviction · adults with antisocial personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global state/functioning · adults with antisocial personality disorder
1 finding from 1 review
Social functioning · adults with antisocial personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Side effects or other adverse events · adults with antisocial personality disorder
1 finding from 1 review
Nausea · women undergoing regional anaesthesia for caesarean section
It is very uncertain whether dopamine antagonists changes nausea ‐ intraoperative compared with placebo (very low certainty).
2 findings from 1 review
Vomiting ‐ intraoperative · women undergoing regional anaesthesia for caesarean section
Dopamine antagonists may leads to lower vomiting ‐ intraoperative compared with placebo (low certainty).
1 finding from 1 review
Vomiting ‐ postoperative · women undergoing regional anaesthesia for caesarean section
It is very uncertain whether dopamine antagonists changes vomiting ‐ postoperative compared with placebo (very low certainty).
1 finding from 1 review
Participants with ≥ 1 vomiting episode · adults receiving intravenous opioids
Prophylactic dopamine antagonist antiemetic medications showed no clear difference in vomiting (≥1 episode) compared with placebo (low certainty).
1 finding from 1 review
Nausea · adults receiving intravenous opioids
Prophylactic dopamine antagonist antiemetic medications showed no clear difference in nausea (≥1 episode) compared with placebo (low certainty).
1 finding from 1 review
Adverse events · adults receiving intravenous opioids
Prophylactic dopamine antagonist antiemetic medications showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Number of vomiting episodes · adults receiving intravenous opioids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea severity · adults receiving intravenous opioids
1 finding from 1 review
Use of rescue medication · adults receiving intravenous opioids
Prophylactic dopamine antagonist antiemetic medications showed no clear difference in rescue medication compared with placebo (low certainty).
1 finding from 1 review
Total sleep time, next night; · patients with restless legs syndrome
1 finding from 1 review
Adverse effects (drop‐outs due to adverse effects4) · patients with restless legs syndrome
Summary of findings: levodopa probably leads to lower number of drop outs due to adverse events compared with other dopamine agonists (moderate certainty).
1 finding from 1 review
Clinical Global Impressions ‐ Improvement of condition (CGI‐I) Rating of 1 = very much improved to 7 = very much worse · patients with restless legs syndrome
1 finding from 1 review